Melissa Hallow, PhD

Founder and Principal Consultant
Cardiorenal QSP, LLC, Georgia, United States

Disclosure information not submitted.

Presentation(s):

• Scaling Peaks Unclimbed: How QSP is Shaping the Future Landscape of MIDD in Diseases Beyond Oncology

  Tuesday, October 21, 2025
  9:00 AM - 10:30 AM MDT

• Quantitative Systems Pharmacology for Cardiorenal Drug Development: Integrating Safety and Efficacy Predictions in patients with multiple comorbidities and comedications

  Tuesday, October 21, 2025
  9:15 AM - 9:35 AM MDT